Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

Share Price is delayed by 15 minutes
Get Live Data
71.50    6.50 (9.92%)
Bid:
68.00
Ask:
73.00
Spread: 5.00 (7.353%)
Market Cap: £56.75m
HDD Live PriceLast checked at - London Stock Exchange

Intraday Hardide Share Chart

AGM Trading Statement

18 Mar 2025 07:00

RNS Number : 9848A
Hardide PLC
18 March 2025
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

18 March 2025

 

Hardide plc

("Hardide", the "Group" or the "Company")

 

AGM Trading Statement

 

Hardide plc (AIM: HDD), the provider of advanced surface coating technology, will be holding its Annual General Meeting at 11.30am today, at which the Chair will provide the following update on trading in the financial year ending 30 September 2025.

Year to date trading is in line with the Board's expectations.

We are pleased to report that we expect revenues for the first half year ending 31 March 2025 ("H1 FY25") to be approximately 30% ahead of the £2.1m reported in the equivalent prior year period ("H1 FY24"). Accordingly, we expect to report a positive EBITDA and a positive cash flow performance in H1 FY25 (H1 FY24: EBITDA loss of £0.5m, cash outflow of £0.7m, prior to proceeds from financing).

Revenue growth is being driven by the further development of our aerospace business, including initial revenues from the new contract announced in December 2024 to coat cargo door components for freight aircraft, together with some recovery in oil and gas sector demand compared with the previous H1.

The management team and the Board remain highly focused on pursuing initiatives to accelerate revenue growth and utilise spare production capacity, as set out in our 2024 annual report. This includes projects to:

· harmonise the production capabilities of our Martinsville factory in the USA with that of Bicester in the UK; and

· broaden the capability of our wet treatment line in the UK to enable this service to be offered directly to customers. Previously this facility has been used solely as a pre-treatment for CVD coatings.

The combined capital cost of these projects will be less than £0.1m, with completion expected in the third quarter of the financial year.

In view of encouraging trading to date, and the fresh approach to growing the business under new management, the Board believes that Hardide remains on track to deliver expectations for full year performance.

 

 

For further information:

Hardide plc

Matt Hamblin (CEO)

Simon Hallam (Finance Director)

Andrew Magson (Non-Executive Chair)

 

Tel: +44 (0) 1869 353 830

 

Cavendish Capital Markets Ltd - Nominated Adviser and Broker

Henrik Persson / Elysia Bough (Corporate Finance)

Jasper Berry / Dale Bellis (Sales)

 

Tel: +44 (0) 2072 200 500

 

Notes to editors:

www.hardide.com

 

Hardide develops, manufactures and applies advanced technology tungsten carbide/tungsten metal matrix coatings to a wide range of engineering components. Its patented technology is unique in combining in one material, a mix of toughness and resistance to abrasion, erosion and corrosion; together with the ability to coat accurately interior surfaces and complex geometries. The material is proven to offer dramatic improvements in component life, particularly when applied to components that operate in very aggressive environments. This results in cost savings through reduced downtime and increased operational efficiency as well as a reduced carbon footprint. Customers include leading companies operating in the energy sectors, valve and pump manufacturing, industrial gas turbine, precision engineering and aerospace industries.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKOBBQBKDFND
Date   Source Headline
19th May 20215:37 pmRNSHolding(s) in Company
18th May 20217:00 amRNSInterim Results
28th Apr 20213:16 pmRNSHolding(s) in Company
19th Mar 20213:19 pmRNSHolding(s) in Company
15th Mar 202112:06 pmRNSResult of AGM
15th Mar 20217:00 amRNSAGM Statement
25th Feb 202110:22 amRNSIssue of Options
19th Feb 20215:01 pmRNSHolding(s) in Company
19th Feb 20217:00 amRNSNotice of AGM
5th Feb 20217:00 amRNSHolding(s) in Company
1st Feb 202110:50 amRNSResult of Fundraising
1st Feb 20217:00 amRNSProposed equity fundraising and CBILS loan
7th Dec 20207:00 amRNSPreliminary results for year ended 30 Sept 2020
23rd Sep 20207:00 amRNSPre-close Trading Update
3rd Aug 20205:24 pmRNSDirector Dealing - Correction
3rd Aug 202012:17 pmRNSDirector Dealing
23rd Jul 20207:00 amRNSResignation of Non-Executive Director
16th Jul 20207:00 amRNSTrading Update
25th Jun 20202:30 pmRNSExercise of Options
23rd Jun 20202:14 pmRNSHolding(s) in Company
17th Jun 20203:43 pmRNSChange of Registered Office
20th May 20204:37 pmRNSIssue of Options
19th May 20207:00 amRNSInterim Results
21st Apr 20207:00 amRNSQueen’s Award for Enterprise
14th Apr 20205:00 pmRNSExercise of Options
31st Mar 20207:00 amRNSTRADING UPDATE AND THE IMPACT OF COVID-19
17th Feb 202012:47 pmRNSResult of AGM
17th Feb 20207:00 amRNSAGM Statement
10th Feb 20207:00 amRNSPresenting at The Growth & Innovation Forum
27th Jan 20202:43 pmRNSHolding(s) in Company
27th Jan 20207:00 amRNSAppointment of Finance Director
21st Jan 20208:15 amRNSDirector/PDMR Shareholding
21st Jan 20207:00 amRNSPlacing to raise £2.5 million
16th Dec 20195:22 pmRNSGrant of Options
9th Dec 20197:00 amRNSPreliminary Results
13th Nov 20197:00 amRNSHardide approved for F-35 Joint Strike Fighter
11th Nov 20197:00 amRNSPatent Award
15th Oct 20198:23 amRNSHolding(s) in Company
26th Sep 20197:00 amRNSTrading Update
23rd Aug 20197:00 amRNSAppointment of Joint Broker
21st Aug 20197:00 amRNSOrders for three new coating reactors
12th Aug 20198:17 amRNSHardide selected for Airbus A330 wing components
8th Jul 20197:00 amRNSContract Award
28th Jun 20197:00 amRNSExercise of Options and Director Shareholdings
11th Jun 20195:00 pmRNSHolding(s) in Company
14th May 20197:00 amRNSInterim Results
14th May 20197:00 amRNSHardide selected for Airbus A380 wing components
13th Mar 20197:00 amRNSHardide Coating Extends Life of Turbine Blades
7th Mar 201911:37 amRNSHolding(s) in Company
7th Mar 201911:36 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.